METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
| Brand name | ACTOPLUS MET |
|---|---|
| Active ingredient | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
| Strength | 850MG;EQ 15MG BASE |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | August 2005 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9320714 | February 2029 | product |
| 9101660 | January 2027 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.